Clinical Trials

Showing trials with last updates posted in 2018.

NCT01642082 | COMPLETED | PHASE2
28 participants

Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2018-03-13
Start Date:
2012-09-30
Completion:
2016-01-31
Conditions
  • Endometrial Adenocarcinoma
  • Endometrial Clear Cell Adenocarcinoma
  • Endometrial Mixed Adenocarcinoma
  • Endometrial Mucinous Adenocarcinoma
  • Endometrial Serous Adenocarcinoma
  • Endometrial Squamous Cell Carcinoma
  • Endometrial Transitional Cell Carcinoma
  • Endometrial Undifferentiated Carcinoma
  • Recurrent Uterine Corpus Carcinoma
Interventions
  • BIOLOGICAL
  • OTHER
Previous
Sorted by latest updates
Next
Showing 40 trials per page